Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Ethical issues of using artificial intelligence in drug development
1
Zitationen
2
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) is being actively integrated into the drug development process, significantly accelerating it and reducing the costs of creating new therapeutic agents. This article examines key areas of AI application in the pharmaceutical industry, including molecular structure prediction, virtual compound screening, optimization of clinical trials, and personalized medicine. Special attention is paid to the ethical issues arising from the use of AI, such as algorithm transparency, accountability for errors, data privacy, technology accessibility, and regulatory challenges. The World Health Organization (WHO) guidelines for managing large multi-modal models in healthcare are analyzed. The article emphasizes the need to strike a balance between innovation and ethical responsibility, as well as to develop a regulatory framework for the safe and effective use of AI in medicine.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.303 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.155 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.555 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.453 Zit.